MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
20 Jul 2022
Historique:
received: 07 06 2022
revised: 13 07 2022
accepted: 18 07 2022
entrez: 27 7 2022
pubmed: 28 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

Inflammatory bowel disease (IBD) includes ulcerative colitis (UC) and Crohn's disease (CD). These are autoimmune diseases of the gastrointestinal tract with a chronic relapsing and remitting course. Due to complex interactions between multiple factors in the etiology of IBD, the discovery of new predictors of disease course and response to therapy, and the development of effective therapies is a significant challenge. The dysregulation of microRNAs (miRNAs), a class of conserved endogenous, small non-coding RNA molecules with a length of 18-25 nucleotides, that regulate gene expression by an RNA interference process, is implicated in the complex pathogenetic context of IBD. Both tissue-derived, circulating, and fecal microRNAs have been explored as promising biomarkers in the diagnosis and the prognosis of disease severity of IBD. In this review, we summarize the expressed miRNA profile in blood, mucosal tissue, and stool and highlight the role of miRNAs as biomarkers with potential diagnostic and therapeutic applications in ulcerative colitis and Crohn's disease. Moreover, we discuss the new perspectives in developing a new screening model for the detection of colorectal cancer (CRC) based on fecal miRNAs.

Identifiants

pubmed: 35887337
pii: ijms23147991
doi: 10.3390/ijms23147991
pmc: PMC9318064
pii:
doi:

Substances chimiques

Biomarkers 0
MicroRNAs 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Aging (Albany NY). 2021 Feb 1;13(3):4634-4646
pubmed: 33535181
Immunol Allergy Clin North Am. 2019 Feb;39(1):63-79
pubmed: 30466773
Gene Ther. 2021 Aug;28(7-8):422-434
pubmed: 32152434
Clin Gastroenterol Hepatol. 2021 Feb;19(2):323-330.e1
pubmed: 32113893
Inflamm Bowel Dis. 2020 Sep 18;26(10):1597-1606
pubmed: 32793975
Inflamm Bowel Dis. 2016 Feb;22(2):327-35
pubmed: 26752469
Cell Host Microbe. 2016 Jan 13;19(1):32-43
pubmed: 26764595
Br J Cancer. 2015 Jan 6;112(1):61-8
pubmed: 25474246
J Crohns Colitis. 2020 Jan 1;14(1):110-117
pubmed: 31209454
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10513-8
pubmed: 18663219
Nat Rev Cancer. 2006 Nov;6(11):857-66
pubmed: 17060945
Curr Genomics. 2010 Nov;11(7):537-61
pubmed: 21532838
Cancer Genomics Proteomics. 2009 Sep-Oct;6(5):281-95
pubmed: 19996134
Gastroenterology. 2014 Feb;146(2):508-19
pubmed: 24148619
Curr Opin Gastroenterol. 2016 Jul;32(4):258-66
pubmed: 27138057
Gastroenterology. 2020 Mar;158(4):947-957.e4
pubmed: 31622624
World J Gastroenterol. 2017 Jan 7;23(1):76-86
pubmed: 28104982
Inflamm Bowel Dis. 2011 Jan;17(1):241-50
pubmed: 20812331
Gastroenterology. 2008 Nov;135(5):1624-1635.e24
pubmed: 18835392
Adv Exp Med Biol. 2016;937:53-69
pubmed: 27573894
J Vis Exp. 2018 Aug 10;(138):
pubmed: 30148479
J Exp Med. 2017 Jun 5;214(6):1737-1752
pubmed: 28487310
J Crohns Colitis. 2019 Oct 28;13(11):1459-1469
pubmed: 31001642
Exp Ther Med. 2020 Feb;19(2):981-989
pubmed: 32010260
Cancer Epidemiol Biomarkers Prev. 2010 Jul;19(7):1766-74
pubmed: 20551304
Biochem Biophys Res Commun. 2020 Jun 18;527(1):153-161
pubmed: 32446360
Therap Adv Gastroenterol. 2015 Jan;8(1):4-22
pubmed: 25553076
Gut. 2015 Jul;64(7):1095-104
pubmed: 25112884
Nat Cell Biol. 2011 Apr;13(4):423-33
pubmed: 21423178
Int J Mol Sci. 2017 Sep 14;18(9):
pubmed: 28906475
Inflamm Bowel Dis. 2019 May 16;25(Suppl 2):S13-S23
pubmed: 31095702
Gut. 2014 Aug;63(8):1247-57
pubmed: 24000293
Front Med (Lausanne). 2020 Sep 02;7:517
pubmed: 32984386
Aliment Pharmacol Ther. 2019 Mar;49(6):733-743
pubmed: 30734320
Am J Physiol Renal Physiol. 2011 Oct;301(4):F793-801
pubmed: 21775484
Int J Mol Sci. 2020 Oct 24;21(21):
pubmed: 33114313
Am J Physiol Gastrointest Liver Physiol. 2020 Aug 1;319(2):G170-G174
pubmed: 32658620
PLoS One. 2010 Oct 05;5(10):
pubmed: 20957151
J Immunol. 2012 Oct 15;189(8):4175-81
pubmed: 22984082
J Crohns Colitis. 2021 Jul 5;15(7):1120-1129
pubmed: 33438008
Cells. 2021 Aug 26;10(9):
pubmed: 34571853
J Immunol. 2012 Oct 15;189(8):3795-9
pubmed: 22984081
Clin Gastroenterol Hepatol. 2019 Apr;17(5):905-913
pubmed: 30223112
PLoS One. 2016 Aug 18;11(8):e0159956
pubmed: 27536783
J Crohns Colitis. 2014 Apr;8(4):288-95
pubmed: 24074875
Cell Death Dis. 2017 Mar 23;8(3):e2699
pubmed: 28333149
Biochem Biophys Res Commun. 2018 Sep 18;503(4):2443-2450
pubmed: 29969632
Front Endocrinol (Lausanne). 2018 Aug 03;9:402
pubmed: 30123182
Front Immunol. 2017 Feb 16;8:118
pubmed: 28261201
J Crohns Colitis. 2012 Oct;6(9):900-4
pubmed: 22386737
Clin Exp Immunol. 2013 Aug;173(2):250-8
pubmed: 23607522
Gut. 2016 Dec;65(12):1938-1950
pubmed: 26338824
J Cell Mol Med. 2016 Oct;20(10):1813-20
pubmed: 27113480
Inflamm Bowel Dis. 2020 May 12;26(6):820-842
pubmed: 31833544
Clin Transl Gastroenterol. 2020 Mar;11(3):e00134
pubmed: 32352717
Biochem Pharmacol. 2021 Jul;189:114432
pubmed: 33513339
Brain Res Bull. 2018 May;139:235-242
pubmed: 29550454
Lab Invest. 2013 Aug;93(8):888-99
pubmed: 23797361
Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1516-21
pubmed: 18227515
Cell Res. 2008 Oct;18(10):997-1006
pubmed: 18766170
Proc Natl Acad Sci U S A. 2018 Oct 2;115(40):E9362-E9370
pubmed: 30224451
Mol Ther Nucleic Acids. 2015 Mar 10;4:e231
pubmed: 25756961
World J Gastroenterol. 2016 Jan 21;22(3):895-905
pubmed: 26811635
Inflamm Bowel Dis. 2018 Jun 8;24(7):1547-1557
pubmed: 29668922
Gastroenterol Hepatol. 2021 Jan;44(1):39-48
pubmed: 32829958
J Med Life. 2019 Apr-Jun;12(2):113-122
pubmed: 31406511
J Biol Chem. 2009 Jul 3;284(27):17897-901
pubmed: 19342379
World J Gastroenterol. 2017 Feb 14;23(6):976-985
pubmed: 28246471
Mol Cancer Ther. 2018 May;17(5):977-987
pubmed: 29545333
PLoS One. 2012;7(2):e31241
pubmed: 22359580
J Gastroenterol Hepatol. 2010 May;25 Suppl 1:S129-33
pubmed: 20586854
Oncol Rep. 2013 Oct;30(4):1949-56
pubmed: 23877086
Acta Biomater. 2022 Jan 15;138:285-300
pubmed: 34800718
Inflamm Bowel Dis. 2017 May;23(5):739-752
pubmed: 28426456
J Crohns Colitis. 2016 Jun;10(6):703-12
pubmed: 26802080
Cancers (Basel). 2020 Aug 05;12(8):
pubmed: 32764361
Curr Med Res Opin. 2020 Sep;36(9):1457-1463
pubmed: 32573307
Am J Physiol Gastrointest Liver Physiol. 2018 Feb 1;314(2):G256-G262
pubmed: 29146677

Auteurs

Letizia Masi (L)

Centro per le Malattie dell'Apparato Digerente (CEMAD), Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Largo A. Gemelli 8, 00168 Roma, Italy.

Ivan Capobianco (I)

Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Roma, Italy.

Carlotta Magrì (C)

Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Roma, Italy.

Irene Marafini (I)

UOC Gastroenterologia ed Endoscopia Digestiva, Dipartimento di Medicina, Fondazione Policlinico Tor Vergata, Viale Oxford 81, 00133 Roma, Italy.

Valentina Petito (V)

Centro per le Malattie dell'Apparato Digerente (CEMAD), Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Largo A. Gemelli 8, 00168 Roma, Italy.

Franco Scaldaferri (F)

Centro per le Malattie dell'Apparato Digerente (CEMAD), Dipartimento di Scienze Mediche e Chirurgiche, Fondazione Policlinico Universitario "A. Gemelli" IRCCS, Largo A. Gemelli 8, 00168 Roma, Italy.
Dipartimento Universitario di Medicina e Chirurgia Traslazionale, Università Cattolica del Sacro Cuore, Largo F. Vito 1, 00168 Roma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH